Subscribe
shutterstock_2026137224_flowersandtraveling
Flowersandtraveling / Shutterstock.com
25 November 2021Americas

Pfizer claims employee stole COVID-19 vaccine documents

Pfizer is currently investigating a soon-to-be former employee who it believes has transferred more than 12,000 files, many of which contain confidential and trade secret information, to her personal devices and has repeatedly attempted to cover her tracks.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Pfizer signs antiviral COVID-19 licence with MPP
18 November 2021   Pfizer is the latest pharmaceutical company to sign a licensing agreement with the Medicines Patent Pool to help increase access to its COVID-19 oral antiviral treatment candidate PAXLOVID for low and middle-income countries.
Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Pfizer signs antiviral COVID-19 licence with MPP
18 November 2021   Pfizer is the latest pharmaceutical company to sign a licensing agreement with the Medicines Patent Pool to help increase access to its COVID-19 oral antiviral treatment candidate PAXLOVID for low and middle-income countries.
Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.

More on this story

Big Pharma
Pfizer signs antiviral COVID-19 licence with MPP
18 November 2021   Pfizer is the latest pharmaceutical company to sign a licensing agreement with the Medicines Patent Pool to help increase access to its COVID-19 oral antiviral treatment candidate PAXLOVID for low and middle-income countries.
Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?